Clinical Activity of AGEN1181 Demonstrated Across Nine Treatment-Resistant Cancers at SITCGlobeNewsWire • 11/12/21
Agenus Inc. (AGEN) CEO Garo Armen on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha • 11/09/21
Agenus to Participate in Fireside Chat at the B. Riley Fall 2021 Growth Biotech Best Ideas SeriesGlobeNewsWire • 11/09/21
Agenus to Participate in Webcast Hosted by William Blair to Discuss AGEN1181 Clinical Data from SITC 2021 MeetingGlobeNewsWire • 11/04/21
Agenus (AGEN) Reports Next Week: Wall Street Expects Earnings GrowthZacks Investment Research • 11/02/21
Down 33.3% in 4 Weeks, Here's Why Agenus (AGEN) Looks Ripe for a TurnaroundZacks Investment Research • 10/26/21
Are Atea Pharmaceuticals, Agenus, Novavax, and Ocular Therapeutix Bad News Buy?The Motley Fool • 10/24/21
Agenus to Receive $20M Milestone Payment from Bristol Myers Squibb with Dosing of First Patient with its TIGIT Bispecific AntibodyGlobeNewsWire • 10/12/21
Combination of Balstilimab Plus Zalifrelimab Doubles Responses in 2L Cervical Cancer in Data to Be Presented at ESMOGlobeNewsWire • 09/16/21
New Agenus Subsidiary, SaponiQx, Builds Innovative Adjuvant Platform and Forms Collaboration with Ginkgo BioworksGlobeNewsWire • 09/10/21